The present invention relates to tetrahydroquinoline compounds as
muscarinic receptor agonists; compositions comprising the same; methods
of inhibiting an activity of a muscarinic receptor with said compounds;
methods of treating a disease condition associated with a muscarinic
receptor using said compounds; and methods for identifying a subject
suitable for treatment using said compounds.